# Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain

> **NCT01967524** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 80 (actual)

## Conditions studied

- Myofascial Pelviperineal Pain

## Interventions

- **DRUG:** botulinum toxin A + ropivacaïne
- **DRUG:** Ropivacaïne

## Key facts

- **NCT ID:** NCT01967524
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01967524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01967524, "Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01967524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*